Contract Pharmaceutical Research Services in the US - Industry Market Research Report
Description
Contract Pharmaceutical Research Services in the US
The industry provides a breadth of research and development (R&D) services to manufacturers in the pharmaceutical industry. Over the past five years, demand for outsourced pharmaceutical research has continued to grow, driven by the rising market penetration of contract research organizations (CROs) and growing demand for new drug manufacturing. Rising vertical integration has enabled businesses in this industry to become a one-stop shop for all client needs. Continued efforts to consolidate have led to some large acquisitions, including the acquisition of PPD Inc. by Thermo Fisher Scientific for $17.4 billion in December 2021. Overall, industry revenue is expected to expand at a CAGR of 4.7% to $17.2 billion over the past five years, including 4.7% growth in 2023 alone.
The industry provides a range of research and development services to pharmaceutical manufacturers, including laboratory testing, preclinical and clinical trials, commercialization and post-market surveillance.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
The industry provides a breadth of research and development (R&D) services to manufacturers in the pharmaceutical industry. Over the past five years, demand for outsourced pharmaceutical research has continued to grow, driven by the rising market penetration of contract research organizations (CROs) and growing demand for new drug manufacturing. Rising vertical integration has enabled businesses in this industry to become a one-stop shop for all client needs. Continued efforts to consolidate have led to some large acquisitions, including the acquisition of PPD Inc. by Thermo Fisher Scientific for $17.4 billion in December 2021. Overall, industry revenue is expected to expand at a CAGR of 4.7% to $17.2 billion over the past five years, including 4.7% growth in 2023 alone.
The industry provides a range of research and development services to pharmaceutical manufacturers, including laboratory testing, preclinical and clinical trials, commercialization and post-market surveillance.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
42 Pages
- ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
